Industries > Pharma > Traveller’s Diarrhoea Treatment Market Report 2021-2031
Traveller’s Diarrhoea Treatment Market Report 2021-2031
By Drug Class (Oral Rehydration Therapy (ORS), Antidiarrheal Agents, Vaccines/prophylactics, and Others), By Pathogen (Bacteria, Viruses, Protozoa, and Giardiasis), By Route of Administration (Oral, and Parenteral), By Patient Demographics (Adults, and Pediatric), By End User (Hospital, Homecare, Specialty Clinics, and Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), and Leading Regional/ Country market analysis
Traveler’s Diarrhea Treatment Market– our new study reveals trends, R&D progress, and predicted revenues
Where the Traveler’s Diarrhea Treatment is market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities, and business prospects there.
Discover how to stay ahead
Our 300+ page report provides 400+ tables and 380+ charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Traveler’s Diarrhea Treatment Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
• Revenue and growth forecasts from 2021 to 2031 for the Global Traveler’s Diarrhea Treatment Market By Drug Class
• Oral Rehydration Therapy (ORS)
• Antidiarrheal Agents
o Antibiotics
o Azithromycin
o Ciprofloxacin
o Quinolones
o Rifaximin
• Vaccines/prophylactics
• Others
• Revenue and growth forecasts from 2021 to 2031 for the Global Traveler’s Diarrhea Treatment Market By Pathogen
• Bacteria
o E. Coli
o Salmonella Spp
o Others
• Viruses
• Protozoa
• Giardiasis
o Cryptosporidium Parvum
o Others
• Revenue and growth forecasts from 2021 to 2031 for the Global Traveler’s Diarrhea Treatment Market By Route of Administration
• Oral
• Parenteral
• Revenue and growth forecasts from 2021 to 2031 for the Global Traveler’s Diarrhea Treatment Market By Patient Demographics
• Adults
• Pediatric
• Revenue and growth forecasts from 2021 to 2031 for the Global Traveler’s Diarrhea Treatment Market By End User
• Hospital
• Homecare
• Specialty Clinics
• Others
• Revenue and growth forecasts from 2021 to 2031 for the Global Traveler’s Diarrhea Treatment Market By Distribution Channel
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Traveler’s Diarrhea Treatment Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Traveler’s Diarrhea Treatment Market will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Traveler’s Diarrhea Treatment Market report helps you
In summary, our 300+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Traveler’s Diarrhea Treatment Market, with forecasts for Get our report today Traveler’s Diarrhea Treatment Market Forecast 2021-2031: By Drug Class, Pathogen, Route of Administration, Patient Demographics, End User, Distribution Channel and Leading Regional/ Country market analysis each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Traveler’s Diarrhea Treatment market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Traveler’s Diarrhea Treatment Market. Some of the company’s profiled in this report include
• Bayer AG
• Merck & Co., Inc
• Johnson & Johnson Services, Inc
• Novartis AG
• Valneva SE
• Shanghai United Cell Biotechnology Co.,Ltd
• PaxVax, Inc
• Immuron
• Salix Pharmaceuticals
• F. Hoffmann-La Roche Ltd
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Traveler’s Diarrhea Treatment Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Traveller’s Diarrhoea Treatment Market Report 2021-2031: By Drug Class (Oral Rehydration Therapy (ORS), Antidiarrheal Agents, Vaccines/prophylactics, and Others), By Pathogen (Bacteria, Viruses, Protozoa, and Giardiasis), By Route of Administration (Oral, and Parenteral), By Patient Demographics (Adults, and Pediatric), By End User (Hospital, Homecare, Specialty Clinics, and Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), and Leading Regional/ Country market analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered By This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Traveler’s Diarrhea Treatment Market
2.1. Traveler’s Diarrhea Treatment Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Condition Submarkets Definitions
3. Traveler’s Diarrhea Treatment Market Overview
3.1. Global Traveler’s Diarrhea Treatment Market Size and Forecast By Region
3.2. Global Traveler’s Diarrhea Treatment Market Share By Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Increasing Prevalence of Traveler's diarrhea
3.3.1.2. Government initiative and awareness program
3.3.1.3. Increasing Geriatric Population around the World
3.3.1.4. Increasing therapeutic advancement
3.3.2. Market Restraints
3.3.2.1. Stringent Regulation associated with product development
3.3.2.2. High Cost of development
3.3.3. Opportunities
3.3.3.1. Increasing research and development for traveler’s diarrhea treatment
3.3.3.2. Increasing investment in traveler’s diarrhea treatment
3.3.4. Challenges
3.3.4.1. Product recall
3.3.4.2. Availability of alternatives
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.1.1. Strength 1
3.3.5.1.2. Strength 2
3.3.5.1.3. Strength 3
3.3.5.2. Weaknesses
3.3.5.2.1. Weakness 1
3.3.5.2.2. Weakness 2
3.3.5.2.3. Weakness 3
3.3.5.3. Opportunities
3.3.5.3.1. Opportunity 1
3.3.5.3.2. Opportunity 2
3.3.5.3.3. Opportunity 3
3.3.5.4. Threats
3.3.5.4.1. Threat 1
3.3.5.4.2. Threat 2
3.3.5.4.3. Threat 3
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast 2021-2031, By Drug Class (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Oral Rehydration Therapy (ORS)
4.1.1.1. Oral Rehydration Therapy (ORS) market size and forecast, 2021-2031 (USD Million)
4.1.2. Antidiarrheal Agents
4.1.2.1. Antidiarrheal Agents market size and forecast, 2021-2031 (USD Million)
4.1.3. Vaccines/prophylactics
4.1.3.1. Vaccines/prophylactics market size and forecast, 2021-2031 (USD Million)
4.1.4. Others
4.1.4.1. Others market size and forecast, 2021-2031 (USD Million)
5. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, 2021-2031 By Pathogen (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Bacteria
5.1.1.1. Bacteria market size and forecast, 2021-2031 (USD Million)
5.1.2. Viruses
5.1.2.1. Viruses market size and forecast, 2021-2031 (USD Million)
5.1.3. Protozoa
5.1.3.1. Protozoa market size and forecast, 2021-2031 (USD Million)
5.1.4. Giardiasis
5.1.4.1. Giardiasis market size and forecast, 2021-2031 (USD Million)
5.1.5. Others
5.1.5.1. Others market size and forecast, 2021-2031 (USD Million)
6. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, 2021-2031 By Patient Demographics (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Geriatric
6.1.1.1. Geriatric market size and forecast, 2021-2031 (USD Million)
6.1.2. Adult
6.1.2.1. Adult market size and forecast, 2021-2031 (USD Million)
6.1.3. Pediatric
6.1.3.1. Pediatric market size and forecast, 2021-2031 (USD Million)
7. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, 2021-2031 By Route of Administration (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Oral
7.1.1.1. Oral market size and forecast, 2021-2031 (USD Million)
7.1.2. Parenteral
7.1.2.1. Parenteral market size and forecast, 2021-2031 (USD Million)
8. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, 2021-2031 By End-User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.1.1. Hospitals
8.1.1.1. Hospitals market size and forecast, 2021-2031 (USD Million)
8.1.2. Homecare
8.1.2.1. Homecare market size and forecast, 2021-2031 (USD Million)
8.1.3. Specialty Clinics
8.1.3.1. Specialty Clinics market size and forecast, 2021-2031 (USD Million)
8.1.4. Others
8.1.4.1. Others market size and forecast, 2021-2031 (USD Million)
9. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, 2021-2031 By Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.1.1. Hospitals Pharmacy
9.1.1.1. 9.1.1. Hospitals Pharmacy market size and forecast, 2021-2031 (USD Million)
9.1.2. Retail Pharmacy
9.1.2.1. Retail Pharmacy market size and forecast, 2021-2031 (USD Million)
9.1.3. Online Pharmacies
9.1.3.1. 9.1.3. Online Pharmacies market size and forecast, 2021-2031 (USD Million)
10. North America Traveler’s Diarrhea Treatment Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. North America Traveler’s Diarrhea Treatment Market Size and Forecast By Drug Class
10.2.1.1. XX Driving/Opportunity Factor
10.2.1.2. XX Driving/Opportunity Factor
10.3. North America Traveler’s Diarrhea Treatment Market Size and Forecast By Pathogen
10.3.1.1. XX Driving/Opportunity Factor
10.3.1.2. XX Driving/Opportunity Factor
10.4. North America Traveler’s Diarrhea Treatment Market Size and Forecast By Route of Administration
10.4.1.1. XX Driving/Opportunity Factor
10.4.1.2. XX Driving/Opportunity Factor
10.5. North America Traveler’s Diarrhea Treatment Market Size and Forecast By Patient Demographics
10.5.1.1. XX Driving/Opportunity Factor
10.5.1.2. XX Driving/Opportunity Factor
10.5.1.3.
10.6. North America Traveler’s Diarrhea Treatment Market Size and Forecast By End-User
10.6.1.1. XX Driving/Opportunity Factor
10.6.1.2. XX Driving/Opportunity Factor
10.7. North America Traveler’s Diarrhea Treatment Market Size and Forecast By Distribution Channel
10.7.1.1. XX Driving/Opportunity Factor
10.7.1.2. XX Driving/Opportunity Factor
10.8. U.S. Traveler’s Diarrhea Treatment Market
10.8.1.1. XX Driving/Opportunity Factor
10.8.1.2. XX Driving/Opportunity Factor
10.9. Canada Traveler’s Diarrhea Treatment Market
10.9.1.1. XX Driving/Opportunity Factor
10.9.1.2. XX Driving/Opportunity Factor
11. Europe Traveler’s Diarrhea Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Europe Traveler’s Diarrhea Treatment Market Size and Forecast By Drug Class
11.2.1.1. XX Driving/Opportunity Factor
11.2.1.2. XX Driving/Opportunity Factor
11.3. Europe Traveler’s Diarrhea Treatment Market Size and Forecast By Pathogen
11.3.1.1. XX Driving/Opportunity Factor
11.3.1.2. XX Driving/Opportunity Factor
11.4. Europe Traveler’s Diarrhea Treatment Market Size and Forecast By Patient Demographics
11.4.1.1. XX Driving/Opportunity Factor
11.4.1.2. XX Driving/Opportunity Factor
11.5. Europe Traveler’s Diarrhea Treatment Market Size and Forecast By Route of Administration
11.5.1.1. XX Driving/Opportunity Factor
11.5.1.2. XX Driving/Opportunity Factor
11.5.1.3.
11.6. Europe Traveler’s Diarrhea Treatment Market Size and Forecast By End-User
11.6.1.1. XX Driving/Opportunity Factor
11.6.1.2. XX Driving/Opportunity Factor
11.7. Europe Traveler’s Diarrhea Treatment Market Size and Forecast By Distribution Channel
11.7.1.1. XX Driving/Opportunity Factor
11.7.1.2. XX Driving/Opportunity Factor
11.8. UK Traveler’s Diarrhea Treatment Market
11.8.1.1. XX Driving/Opportunity Factor
11.8.1.2. XX Driving/Opportunity Factor
11.9. Germany Traveler’s Diarrhea Treatment Market
11.9.1.1. XX Driving/Opportunity Factor
11.9.1.2. XX Driving/Opportunity Factor
11.10. France Traveler’s Diarrhea Treatment Market
11.10.1.1. XX Driving/Opportunity Factor
11.10.1.2. XX Driving/Opportunity Factor
11.11. Rest of Europe Traveler’s Diarrhea Treatment Market
11.11.1.1. XX Driving/Opportunity Factor
11.11.1.2. XX Driving/Opportunity Factor
12. Asia Pacific Traveler’s Diarrhea Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Asia-Pacific Traveler’s Diarrhea Treatment Market Size and Forecast By Drug Class
12.2.1.1. XX Driving/Opportunity Factor
12.2.1.2. XX Driving/Opportunity Factor
12.3. Asia-Pacific Traveler’s Diarrhea Treatment Market Size and Forecast By Pathogen
12.3.1.1. XX Driving/Opportunity Factor
12.3.1.2. XX Driving/Opportunity Factor
12.4. Asia-Pacific Traveler’s Diarrhea Treatment Market Size and Forecast By Patient Demographics
12.4.1.1. XX Driving/Opportunity Factor
12.4.1.2. XX Driving/Opportunity Factor
12.5. Asia-Pacific Traveler’s Diarrhea Treatment Market Size and Forecast By Route of Administration
12.5.1.1. XX Driving/Opportunity Factor
12.5.1.2. XX Driving/Opportunity Factor
12.6. Asia-Pacific Traveler’s Diarrhea Treatment Market Size and Forecast By End-User
12.6.1.1. XX Driving/Opportunity Factor
12.6.1.2. XX Driving/Opportunity Factor
12.7. Asia-Pacific Traveler’s Diarrhea Treatment Market Size and Forecast By Distribution Channel
12.7.1.1. XX Driving/Opportunity Factor
12.7.1.2. XX Driving/Opportunity Factor
12.8. China Traveler’s Diarrhea Treatment Market
12.8.1.1. XX Driving/Opportunity Factor
12.8.1.2. XX Driving/Opportunity Factor
12.9. India Traveler’s Diarrhea Treatment Market
12.9.1.1. XX Driving/Opportunity Factor
12.9.1.2. XX Driving/Opportunity Factor
12.10. Japan Traveler’s Diarrhea Treatment Market
12.10.1.1. XX Driving/Opportunity Factor
12.10.1.2. XX Driving/Opportunity Factor
12.11. Rest of Asia Pacific Traveler’s Diarrhea Treatment Market
12.11.1.1. XX Driving/Opportunity Factor
12.11.1.2. XX Driving/Opportunity Factor
13. Latin America Traveler’s Diarrhea Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
13.1. Market Overview
13.2. Latin America Traveler’s Diarrhea Treatment Market Size and Forecast By Drug Class
13.2.1.1. XX Driving/Opportunity Factor
13.2.1.2. XX Driving/Opportunity Factor
13.3. Latin America Traveler’s Diarrhea Treatment Market Size and Forecast By Pathogen
13.3.1.1. XX Driving/Opportunity Factor
13.3.1.2. XX Driving/Opportunity Factor
13.4. Latin America Traveler’s Diarrhea Treatment Market Size and Forecast By Patient Demographics
13.4.1.1. XX Driving/Opportunity Factor
13.4.1.2. XX Driving/Opportunity Factor
13.5. Latin America Traveler’s Diarrhea Treatment Market Size and Forecast By Route of Administration
13.5.1.1. XX Driving/Opportunity Factor
13.5.1.2. XX Driving/Opportunity Factor
13.6. Latin America Traveler’s Diarrhea Treatment Market Size and Forecast By End-User
13.6.1.1. XX Driving/Opportunity Factor
13.6.1.2. XX Driving/Opportunity Factor
13.7. Latin America Traveler’s Diarrhea Treatment Market Size and Forecast By Distribution Channel
13.8. Brazil Traveler’s Diarrhea Treatment Market
13.8.1.1. XX Driving/Opportunity Factor
13.8.1.2. XX Driving/Opportunity Factor
13.9. Mexico Traveler’s Diarrhea Treatment Market
13.9.1.1. XX Driving/Opportunity Factor
13.9.1.2. XX Driving/Opportunity Factor
13.10. Rest of Latin America Traveler’s Diarrhea Treatment Market
13.10.1.1. XX Driving/Opportunity Factor
13.10.1.2. XX Driving/Opportunity Factor
14. MEA Traveler’s Diarrhea Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
14.1. Market Overview
14.2. MEA Traveler’s Diarrhea Treatment Market Size and Forecast By Drug Class
14.2.1.1. XX Driving/Opportunity Factor
14.2.1.2. XX Driving/Opportunity Factor
14.3. MEA Traveler’s Diarrhea Treatment Market Size and Forecast By Pathogen
14.3.1.1. XX Driving/Opportunity Factor
14.3.1.2. XX Driving/Opportunity Factor
14.4. MEA Traveler’s Diarrhea Treatment Market Size and Forecast By Patient Demographics
14.4.1.1. XX Driving/Opportunity Factor
14.4.1.2. XX Driving/Opportunity Factor
14.5. MEA Traveler’s Diarrhea Treatment Market Size and Forecast By Route of Administration
14.5.1.1. XX Driving/Opportunity Factor
14.5.1.2. XX Driving/Opportunity Factor
14.6. MEA Traveler’s Diarrhea Treatment Market Size and Forecast By End-User
14.6.1.1. XX Driving/Opportunity Factor
14.6.1.2. XX Driving/Opportunity Factor
14.7. MEA Traveler’s Diarrhea Treatment Market Size and Forecast By Distribution Channel
14.7.1.1. XX Driving/Opportunity Factor
14.7.1.2. XX Driving/Opportunity Factor
14.8. GCC Traveler’s Diarrhea Treatment Market
14.8.1.1. XX Driving/Opportunity Factor
14.8.1.2. XX Driving/Opportunity Factor
14.9. South Africa Traveler’s Diarrhea Treatment Market
14.9.1.1. XX Driving/Opportunity Factor
14.9.1.2. XX Driving/Opportunity Factor
14.10. Rest of MEA Traveler’s Diarrhea Treatment Market
14.10.1.1. XX Driving/Opportunity Factor
14.10.1.2. XX Driving/Opportunity Factor
15. Companies in the Traveler’s Diarrhea Treatment Market
15.1. Bayer AG
15.1.1. Company Snapshot
15.1.2. Company Overview
15.1.3. Financial Performance (2015-2019)
15.1.3.1. Net Revenue
15.1.3.2. Gross Profit
15.1.3.3. Geographical Revenue, 2019
15.1.4. Product Offerings
15.1.5. Recent Initiatives (2017-2019)
15.2. Merck & Co., Inc
15.2.1. Company Snapshot
15.2.2. Company Overview
15.2.3. Financial Performance (2015-2019)
15.2.3.1. Net Revenue
15.2.3.2. Gross Profit
15.2.3.3. Geographical Revenue, 2019
15.2.4. Product Offerings
15.2.5. Recent Initiatives (2017-2019)
15.3. Johnson & Johnson Services, Inc
15.3.1. Company Snapshot
15.3.2. Company Overview
15.3.3. Financial Performance (2015-2019)
15.3.3.1. Net Revenue
15.3.3.2. Gross Profit
15.3.3.3. Geographical Revenue, 2019
15.3.4. Product Offerings
15.3.5. Recent Initiatives (2017-2019)
15.4. NOVARTIS AG
15.4.1. Company Snapshot
15.4.2. Company Overview
15.4.3. Financial Performance (2015-2019)
15.4.3.1. Net Revenue
15.4.3.2. Gross Profit
15.4.3.3. Geographical Revenue, 2019
15.4.4. Product Offerings
15.4.5. Recent Initiatives (2017-2019)
15.5. VALNEVA SE
15.5.1. Company Snapshot
15.5.2. Company Overview
15.5.3. Financial Performance (2015-2019)
15.5.3.1. Net Revenue
15.5.3.2. Gross Profit
15.5.3.3. Geographical Revenue, 2019
15.5.4. Product Offerings
15.5.5. Recent Initiatives (2017-2019)
15.6. Shanghai United Cell Biotechnology Co.,Ltd
15.6.1. Company Snapshot
15.6.2. Company Overview
15.6.3. Financial Performance (2015-2019)
15.6.3.1. Net Revenue
15.6.3.2. Gross Profit
15.6.3.3. Geographical Revenue, 2019
15.6.4. Product Offerings
15.6.5. Recent Initiatives (2017-2019)
15.7. PaxVax, Inc
15.7.1. Company Snapshot
15.7.2. Company Overview
15.7.3. Financial Performance (2015-2019)
15.7.3.1. Net Revenue
15.7.3.2. Gross Profit
15.7.3.3. Geographical Revenue, 2019
15.7.4. Product Offerings
15.7.5. Recent Initiatives (2017-2019)
15.8. Immuron
15.8.1. Company Snapshot
15.8.2. Company Overview
15.8.3. Financial Performance (2015-2019)
15.8.3.1. Net Revenue
15.8.3.2. Gross Profit
15.8.3.3. Geographical Revenue, 2019
15.8.4. Product Offerings
15.8.5. Recent Initiatives (2017-2019)
15.9. Salix Pharmaceuticals
15.9.1. Company Snapshot
15.9.2. Company Overview
15.9.3. Financial Performance (2015-2019)
15.9.3.1. Net Revenue
15.9.3.2. Gross Profit
15.9.3.3. Geographical Revenue, 2019
15.9.4. Product Offerings
15.9.5. Recent Initiatives (2017-2019)
15.10. F. Hoffmann-La Roche Ltd
15.10.1. Company Snapshot
15.10.2. Company Overview
15.10.3. Financial Performance (2015-2019)
15.10.3.1. Net Revenue
15.10.3.2. Gross Profit
15.10.3.3. Geographical Revenue, 2019
15.10.4. Product Offerings
15.10.5. Recent Initiatives (2017-2019)
15.11. Other Notable Players
16. Conclusion
17. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Traveler’s Diarrhea Treatment Market Drivers & Restraints 2021
Table 7. Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Antidiarrheal Agents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Antidiarrheal Agents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Antidiarrheal Agents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Antidiarrheal Agents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Antidiarrheal Agents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Vaccines/prophylactics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Vaccines/prophylactics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Vaccines/prophylactics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Vaccines/prophylactics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Vaccines/prophylactics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Bacteria Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Bacteria Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Bacteria Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Bacteria Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Bacteria Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Viruses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Viruses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Viruses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Viruses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Viruses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Giardiasis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Giardiasis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Giardiasis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Giardiasis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Giardiasis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Protozoa Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Protozoa Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Protozoa Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Protozoa Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Protozoa Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78. Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 79. Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 80. Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 81. Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 82. Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 83. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 84. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 85. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 86. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 87. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 88. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 89. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 90. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 91. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 92. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 93. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 94. Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 95. Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 96. Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 97. Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 98. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 99. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 100. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 101. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 102. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 103. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 104. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 105. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 106. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 107. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 108. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 109. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 110. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 111. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 112. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 113. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 114. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 115. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 116. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 117. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 118. Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 119. Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 120. Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 121. Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 122. Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 123. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 124. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 125. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 126. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 127. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 128. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 129. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 130. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 131. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 132. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 133. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 134. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 135. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 136. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 137. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 138. North America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 139. North America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 140. North America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 141. North America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 142. North America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 143. North America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 144. North America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 145. North America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 146. North America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 147. North America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 148. North America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 149. North America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 150. North America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 151. North America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 152. North America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 153. North America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 154. North America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 155. North America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 156. North America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 157. North America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 158. North America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 159. North America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 160. North America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 161. North America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 162. North America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 163. North America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 164. North America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 165. North America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 166. North America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 167. North America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 168. North America Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 169. North America Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 170. North America Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 171. North America Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 172. North America Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 173. US Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 174. US Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 175. US Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 176. US Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 177. US Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 178. Canada Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 179. Canada Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 180. Canada Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 181. Canada Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 182. Canada Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 183. Europe Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Table 184. Europe Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 185. Europe Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 186. Europe Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 187. Europe Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 188. Europe Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 189. Europe Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 190. Europe Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 191. Europe Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 192. Europe Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 193. Europe Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 194. Europe Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 195. Europe Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 196. Europe Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 197. Europe Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 198. Europe Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. Europe Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. Europe Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. Europe Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Europe Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203. Europe Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. Europe Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205. Europe Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. Europe Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. Europe Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208. Europe Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209. Europe Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. Europe Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. Europe Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212. Europe Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 213. Europe Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 214. Europe Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 215. Europe Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 216. UK Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 217. UK Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 218. UK Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 219. UK Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 220. UK Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 221. Germany Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 222. Germany Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 223. Germany Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 224. Germany Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 225. Germany Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 226. France Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 227. France Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 228. France Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 229. France Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 230. France Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 231. Rest of Europe Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 232. Rest of Europe Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233. Rest of Europe Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234. Rest of Europe Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235. Rest of Europe Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 237. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 238. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 239. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 240. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 241. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 242. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 243. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 244. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 245. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 246. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 247. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 248. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 249. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 250. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 251. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 252. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 253. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 254. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 255. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 256. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 257. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 258. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 259. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 260. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 261. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 262. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 263. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 264. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 265. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 266. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 267. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 268. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 269. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 270. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 271. China Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 272. China Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 273. China Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 274. China Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 275. China Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 276. India Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 277. India Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 278. India Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 279. India Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 280. India Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 281. Japan Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 282. Japan Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 283. Japan Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 284. Japan Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 285. Japan Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 286. RoAPAC Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 287. RoAPAC Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 288. RoAPAC Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 289. RoAPAC Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 290. RoAPAC Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 291. Middle East Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 292. Middle East Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 293. Middle East Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 294. Middle East Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 295. Middle East Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 296. Middle East Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 297. Middle East Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 298. Middle East Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 299. Middle East Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 300. Middle East Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 301. Middle East Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 302. Middle East Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 303. Middle East Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 304. Middle East Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 305. Middle East Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 306. Middle East Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 307. Middle East Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 308. Middle East Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 309. Middle East Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 310. Middle East Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 311. Middle East Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 312. Middle East Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 313. Middle East Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 314. Middle East Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 315. Middle East Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 316. Middle East Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 317. Middle East Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 318. Middle East Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 319. Middle East Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 320. Middle East Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 321. Latin America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 322. Latin America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 323. Latin America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 324. Latin America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 325. Latin America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 326. Latin America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 327. Latin America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 328. Latin America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 329. Latin America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 330. Latin America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 331. Latin America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 332. Latin America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 333. Latin America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 334. Latin America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 335. Latin America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 336. Latin America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 337. Latin America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 338. Latin America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 339. Latin America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 340. Latin America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 341. Latin America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 342. Latin America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 343. Latin America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 344. Latin America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 345. Latin America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 346. Latin America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 347. Latin America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 348. Latin America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 349. Latin America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 350. Latin America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 351. Africa Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 352. Africa Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 353. Africa Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 354. Africa Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 355. Africa Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 356. Africa Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 357. Africa Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 358. Africa Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 359. Africa Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 360. Africa Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 361. Africa Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 362. Africa Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 363. Africa Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 364. Africa Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 365. Africa Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 366. Africa Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 367. Africa Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 368. Africa Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 369. Africa Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 370. Africa Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 371. Africa Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 372. Africa Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 373. Africa Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 374. Africa Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 375. Africa Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 376. Africa Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 377. Africa Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 378. Africa Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 379. Africa Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 380. Africa Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 381. Leading 10 Traveler’s Diarrhea Treatment Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 382. Bayer AG Profile 2019 (CEO, HQ, Founded, Website)
Table 383. Bayer AG Traveler’s Diarrhea Treatment Product Offering (Segment, Product Offerings)
Table 384. Merck & Co., IncProfile 2019 (CEO, HQ, Founded, Website)
Table 385. Merck & Co., IncTraveler’s Diarrhea Treatment Product Offering (Segment, Product Offerings)
Table 386. Johnson & Johnson Services, Inc Profile 2019 (CEO, HQ, Founded, Website)
Table 387. Johnson & Johnson Services, Inc.Traveler’s Diarrhea Treatment Product Offering (Segment, Product Offerings)
Table 388. NOVARTIS AG Profile 2019 (CEO, HQ, Founded, Website)
Table 389. NOVARTIS AG Traveler’s Diarrhea Treatment Product Offering (Segment, Product Offerings)
Table 390. VALNEVA SE Profile 2019 (CEO, HQ, Founded, Website)
Table 391. VALNEVA SE Traveler’s Diarrhea Treatment Product Offering (Segment, Product Offerings)
Table 392. Shanghai United Cell Biotechnology Co.,Ltd Profile 2019 (CEO, HQ, Founded, Website)
Table 393. Shanghai United Cell Biotechnology Co.,Ltd Traveler’s Diarrhea Treatment Product Offering (Segment, Product Offerings)
Table 394. PaxVax, Inc Profile 2019 (CEO, HQ, Founded, Website)
Table 395. PaxVax, Inc Traveler’s Diarrhea Treatment Product Offering (Segment, Product Offerings)
Table 396. Immuron Profile 2019 (CEO, HQ, Founded, Website)
Table 397. Immuron Traveler’s Diarrhea Treatment Product Offering (Segment, Product Offerings)
Table 398. Salix Pharmaceuticals Profile 2019 (CEO, HQ, Founded, Website)
Table 399. Salix Pharmaceuticals Traveler’s Diarrhea Treatment Product Offering (Segment, Product Offerings)
Table 400. F. Hoffmann-La Roche Ltd Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 401. F. Hoffmann-La Roche Ltd Traveler’s Diarrhea Treatment Product Offering (Segment, Product Offerings)
Table 402. Other Companies Involved in the Traveler’s Diarrhea Treatment Market 2021 (Company, Location)
LIST OF FIGURES
Figure 1. Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 2. Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 3. Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 4. Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 5. Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 6. Traveler’s Diarrhea Treatment Market Drivers & Restraints 2021
Figure 7. Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 8. Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 9. Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 10. Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 11. Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 12. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 13. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 14. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 15. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 16. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 17. Antidiarrheal Agents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 18. Antidiarrheal Agents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 19. Antidiarrheal Agents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 20. Antidiarrheal Agents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 21. Antidiarrheal Agents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 22. Vaccines/prophylactics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 23. Vaccines/prophylactics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 24. Vaccines/prophylactics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 25. Vaccines/prophylactics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 26. Vaccines/prophylactics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 27. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 28. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 29. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 30. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 31. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 32. Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 33. Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 34. Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 35. Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 36. Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 37. Bacteria Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 38. Bacteria Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 39. Bacteria Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 40. Bacteria Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 41. Bacteria Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 42. Viruses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 43. Viruses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 44. Viruses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 45. Viruses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 46. Viruses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 47. Giardiasis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 48. Giardiasis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 49. Giardiasis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 50. Giardiasis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 51. Giardiasis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 52. Protozoa Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 53. Protozoa Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 54. Protozoa Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 55. Protozoa Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 56. Protozoa Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 57. Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 58. Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 59. Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 60. Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 61. Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 62. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 63. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 64. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 65. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 66. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 67. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 68. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 69. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 70. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 71. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 72. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 73. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 74. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 75. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 76. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 77. Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 78. Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 79. Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 80. Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 81. Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 82. Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 83. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 84. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 85. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 86. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 87. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 88. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 89. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 90. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 91. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 92. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 93. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 94. Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 95. Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 96. Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 97. Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 98. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 99. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 100. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 101. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 102. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 103. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 104. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 105. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 106. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 107. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 108. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 109. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 110. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 111. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 112. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 113. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 114. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 115. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 116. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 117. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 118. Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 119. Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 120. Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 121. Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 122. Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 123. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 124. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 125. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 126. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 127. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 128. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 129. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 130. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 131. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 132. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 133. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 134. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 135. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 136. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 137. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 138. North America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 139. North America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 140. North America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 141. North America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 142. North America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 143. North America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 144. North America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 145. North America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 146. North America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 147. North America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 148. North America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 149. North America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 150. North America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 151. North America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 152. North America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 153. North America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 154. North America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 155. North America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 156. North America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 157. North America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 158. North America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 159. North America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 160. North America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 161. North America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 162. North America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 163. North America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 164. North America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 165. North America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 166. North America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 167. North America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 168. North America Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 169. North America Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 170. North America Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 171. North America Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 172. North America Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 173. US Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 174. US Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 175. US Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 176. US Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 177. US Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 178. Canada Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 179. Canada Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 180. Canada Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 181. Canada Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 182. Canada Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 183. Europe Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Figure 184. Europe Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 185. Europe Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 186. Europe Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 187. Europe Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 188. Europe Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 189. Europe Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 190. Europe Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 191. Europe Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 192. Europe Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 193. Europe Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 194. Europe Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 195. Europe Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 196. Europe Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 197. Europe Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 198. Europe Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 199. Europe Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 200. Europe Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 201. Europe Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 202. Europe Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 203. Europe Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 204. Europe Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 205. Europe Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 206. Europe Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 207. Europe Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 208. Europe Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 209. Europe Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 210. Europe Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 211. Europe Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 212. Europe Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 213. Europe Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 214. Europe Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 215. Europe Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 216. UK Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 217. UK Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 218. UK Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 219. UK Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 220. UK Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 221. Germany Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 222. Germany Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 223. Germany Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 224. Germany Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 225. Germany Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 226. France Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 227. France Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 228. France Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 229. France Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 230. France Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 231. Rest of Europe Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 232. Rest of Europe Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 233. Rest of Europe Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 234. Rest of Europe Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 235. Rest of Europe Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 236. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 237. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 238. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 239. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 240. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 241. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 242. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 243. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 244. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 245. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 246. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 247. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 248. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 249. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 250. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 251. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 252. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 253. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 254. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 255. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 256. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 257. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 258. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 259. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 260. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 261. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 262. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 263. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 264. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 265. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 266. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 267. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 268. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 269. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 270. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 271. China Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 272. China Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 273. China Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 274. China Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 275. China Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 276. India Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 277. India Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 278. India Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 279. India Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 280. India Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 281. Japan Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 282. Japan Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 283. Japan Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 284. Japan Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 285. Japan Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 286. RoAPAC Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 287. RoAPAC Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 288. RoAPAC Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 289. RoAPAC Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 290. RoAPAC Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 291. Middle East Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 292. Middle East Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 293. Middle East Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 294. Middle East Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 295. Middle East Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 296. Middle East Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 297. Middle East Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 298. Middle East Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 299. Middle East Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 300. Middle East Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 301. Middle East Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 302. Middle East Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 303. Middle East Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 304. Middle East Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 305. Middle East Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 306. Middle East Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 307. Middle East Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 308. Middle East Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 309. Middle East Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 310. Middle East Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 311. Middle East Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 312. Middle East Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 313. Middle East Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 314. Middle East Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 315. Middle East Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 316. Middle East Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 317. Middle East Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 318. Middle East Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 319. Middle East Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 320. Middle East Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 321. Latin America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 322. Latin America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 323. Latin America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 324. Latin America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 325. Latin America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 326. Latin America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 327. Latin America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 328. Latin America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 329. Latin America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 330. Latin America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 331. Latin America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 332. Latin America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 333. Latin America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 334. Latin America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 335. Latin America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 336. Latin America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 337. Latin America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 338. Latin America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 339. Latin America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 340. Latin America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 341. Latin America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 342. Latin America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 343. Latin America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 344. Latin America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 345. Latin America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 346. Latin America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 347. Latin America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 348. Latin America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 349. Latin America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 350. Latin America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 351. Africa Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 352. Africa Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 353. Africa Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 354. Africa Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 355. Africa Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 356. Africa Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 357. Africa Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 358. Africa Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 359. Africa Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 360. Africa Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 361. Africa Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 362. Africa Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 363. Africa Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 364. Africa Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 365. Africa Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 366. Africa Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 367. Africa Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 368. Africa Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 369. Africa Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 370. Africa Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 371. Africa Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 372. Africa Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 373. Africa Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 374. Africa Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 375. Africa Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 376. Africa Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 377. Africa Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 378. Africa Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 379. Africa Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 380. Africa Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 381. Porter’s Five Force Analysis
Companies Mentioned
1. Basilea Pharmaceutica Ltd
2. Eli Lilly and Company
3. Delcath Systems Inc
4. BridgeBio Inc
5. Agios, Inc
6. GlaxoSmithKline PLC
7. Biomarin Pharmaceutical Inc
8. Grifols SA
9. UCB SA
10. Eisai Co Ltd
11. Novo Nordisk A/S
12. Alexion Pharmaceuticals Inc
13. Takeda Pharmaceutical Co Ltd
14. Chugai Pharmaceutical Co Ltd
15. Perrigo Company PLC
16. Astellas Pharma Inc
17. Mitsubishi Tanabe Pharma Corp
18. Johnson & Johnson
19. Shanghai Fosun Pharmaceutical Group Co Ltd
20. Jiangsu Hengrui Medicine Co Ltd
21. Allergan plc
22. Shire PLC
23. Kyowa Hakko Kirin Co Ltd
24. Pfizer Inc
25. Taisho Pharmaceutical Holdings Co Ltd
26. MYL.O
27. Zoetis Inc
28. Bristol-Myers Squibb Co
29. Merck & Co Inc
30. AbbVie Inc
31. Jazz Pharmaceuticals PLC
32. Sumitomo Dainippon Pharma Co Ltd
33. AstraZeneca PLC
34. China Grand Automotive Services Co Ltd
35. Daiichi Sankyo Co Ltd
36. Novartis AG
37. Tasly Pharmaceutical Group Co Ltd
38. CSL Ltd
39. Biogen Inc
40. Orion Oyj
41. Bayer AG
42. CSPC Pharmaceutical Group Ltd
43. Sanofi SA
44. Roche Holding AG
45. Ono Pharmaceutical Co Ltd
46. Beijing Tongrentang Co Ltd
47. Kangmei Pharmaceutical Co Ltd
48. Ipsen SA
49. Abbott Laboratories
50. Shionogi & Co Ltd
51. Eli Lilly and Co
52. Recordati Industria Chimica e Farmaceutica SpA
53. Hikma Pharmaceuticals PLC
54. Teva Pharmaceutical Industries Ltd
55. Merck KGaA
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered By This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Traveler’s Diarrhea Treatment Market
2.1. Traveler’s Diarrhea Treatment Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Condition Submarkets Definitions
3. Traveler’s Diarrhea Treatment Market Overview
3.1. Global Traveler’s Diarrhea Treatment Market Size and Forecast By Region
3.2. Global Traveler’s Diarrhea Treatment Market Share By Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Increasing Prevalence of Traveler's diarrhea
3.3.1.2. Government initiative and awareness program
3.3.1.3. Increasing Geriatric Population around the World
3.3.1.4. Increasing therapeutic advancement
3.3.2. Market Restraints
3.3.2.1. Stringent Regulation associated with product development
3.3.2.2. High Cost of development
3.3.3. Opportunities
3.3.3.1. Increasing research and development for traveler’s diarrhea treatment
3.3.3.2. Increasing investment in traveler’s diarrhea treatment
3.3.4. Challenges
3.3.4.1. Product recall
3.3.4.2. Availability of alternatives
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.1.1. Strength 1
3.3.5.1.2. Strength 2
3.3.5.1.3. Strength 3
3.3.5.2. Weaknesses
3.3.5.2.1. Weakness 1
3.3.5.2.2. Weakness 2
3.3.5.2.3. Weakness 3
3.3.5.3. Opportunities
3.3.5.3.1. Opportunity 1
3.3.5.3.2. Opportunity 2
3.3.5.3.3. Opportunity 3
3.3.5.4. Threats
3.3.5.4.1. Threat 1
3.3.5.4.2. Threat 2
3.3.5.4.3. Threat 3
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast 2021-2031, By Drug Class (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Oral Rehydration Therapy (ORS)
4.1.1.1. Oral Rehydration Therapy (ORS) market size and forecast, 2021-2031 (USD Million)
4.1.2. Antidiarrheal Agents
4.1.2.1. Antidiarrheal Agents market size and forecast, 2021-2031 (USD Million)
4.1.3. Vaccines/prophylactics
4.1.3.1. Vaccines/prophylactics market size and forecast, 2021-2031 (USD Million)
4.1.4. Others
4.1.4.1. Others market size and forecast, 2021-2031 (USD Million)
5. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, 2021-2031 By Pathogen (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Bacteria
5.1.1.1. Bacteria market size and forecast, 2021-2031 (USD Million)
5.1.2. Viruses
5.1.2.1. Viruses market size and forecast, 2021-2031 (USD Million)
5.1.3. Protozoa
5.1.3.1. Protozoa market size and forecast, 2021-2031 (USD Million)
5.1.4. Giardiasis
5.1.4.1. Giardiasis market size and forecast, 2021-2031 (USD Million)
5.1.5. Others
5.1.5.1. Others market size and forecast, 2021-2031 (USD Million)
6. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, 2021-2031 By Patient Demographics (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Geriatric
6.1.1.1. Geriatric market size and forecast, 2021-2031 (USD Million)
6.1.2. Adult
6.1.2.1. Adult market size and forecast, 2021-2031 (USD Million)
6.1.3. Pediatric
6.1.3.1. Pediatric market size and forecast, 2021-2031 (USD Million)
7. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, 2021-2031 By Route of Administration (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Oral
7.1.1.1. Oral market size and forecast, 2021-2031 (USD Million)
7.1.2. Parenteral
7.1.2.1. Parenteral market size and forecast, 2021-2031 (USD Million)
8. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, 2021-2031 By End-User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.1.1. Hospitals
8.1.1.1. Hospitals market size and forecast, 2021-2031 (USD Million)
8.1.2. Homecare
8.1.2.1. Homecare market size and forecast, 2021-2031 (USD Million)
8.1.3. Specialty Clinics
8.1.3.1. Specialty Clinics market size and forecast, 2021-2031 (USD Million)
8.1.4. Others
8.1.4.1. Others market size and forecast, 2021-2031 (USD Million)
9. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, 2021-2031 By Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.1.1. Hospitals Pharmacy
9.1.1.1. 9.1.1. Hospitals Pharmacy market size and forecast, 2021-2031 (USD Million)
9.1.2. Retail Pharmacy
9.1.2.1. Retail Pharmacy market size and forecast, 2021-2031 (USD Million)
9.1.3. Online Pharmacies
9.1.3.1. 9.1.3. Online Pharmacies market size and forecast, 2021-2031 (USD Million)
10. North America Traveler’s Diarrhea Treatment Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. North America Traveler’s Diarrhea Treatment Market Size and Forecast By Drug Class
10.2.1.1. XX Driving/Opportunity Factor
10.2.1.2. XX Driving/Opportunity Factor
10.3. North America Traveler’s Diarrhea Treatment Market Size and Forecast By Pathogen
10.3.1.1. XX Driving/Opportunity Factor
10.3.1.2. XX Driving/Opportunity Factor
10.4. North America Traveler’s Diarrhea Treatment Market Size and Forecast By Route of Administration
10.4.1.1. XX Driving/Opportunity Factor
10.4.1.2. XX Driving/Opportunity Factor
10.5. North America Traveler’s Diarrhea Treatment Market Size and Forecast By Patient Demographics
10.5.1.1. XX Driving/Opportunity Factor
10.5.1.2. XX Driving/Opportunity Factor
10.5.1.3.
10.6. North America Traveler’s Diarrhea Treatment Market Size and Forecast By End-User
10.6.1.1. XX Driving/Opportunity Factor
10.6.1.2. XX Driving/Opportunity Factor
10.7. North America Traveler’s Diarrhea Treatment Market Size and Forecast By Distribution Channel
10.7.1.1. XX Driving/Opportunity Factor
10.7.1.2. XX Driving/Opportunity Factor
10.8. U.S. Traveler’s Diarrhea Treatment Market
10.8.1.1. XX Driving/Opportunity Factor
10.8.1.2. XX Driving/Opportunity Factor
10.9. Canada Traveler’s Diarrhea Treatment Market
10.9.1.1. XX Driving/Opportunity Factor
10.9.1.2. XX Driving/Opportunity Factor
11. Europe Traveler’s Diarrhea Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Europe Traveler’s Diarrhea Treatment Market Size and Forecast By Drug Class
11.2.1.1. XX Driving/Opportunity Factor
11.2.1.2. XX Driving/Opportunity Factor
11.3. Europe Traveler’s Diarrhea Treatment Market Size and Forecast By Pathogen
11.3.1.1. XX Driving/Opportunity Factor
11.3.1.2. XX Driving/Opportunity Factor
11.4. Europe Traveler’s Diarrhea Treatment Market Size and Forecast By Patient Demographics
11.4.1.1. XX Driving/Opportunity Factor
11.4.1.2. XX Driving/Opportunity Factor
11.5. Europe Traveler’s Diarrhea Treatment Market Size and Forecast By Route of Administration
11.5.1.1. XX Driving/Opportunity Factor
11.5.1.2. XX Driving/Opportunity Factor
11.5.1.3.
11.6. Europe Traveler’s Diarrhea Treatment Market Size and Forecast By End-User
11.6.1.1. XX Driving/Opportunity Factor
11.6.1.2. XX Driving/Opportunity Factor
11.7. Europe Traveler’s Diarrhea Treatment Market Size and Forecast By Distribution Channel
11.7.1.1. XX Driving/Opportunity Factor
11.7.1.2. XX Driving/Opportunity Factor
11.8. UK Traveler’s Diarrhea Treatment Market
11.8.1.1. XX Driving/Opportunity Factor
11.8.1.2. XX Driving/Opportunity Factor
11.9. Germany Traveler’s Diarrhea Treatment Market
11.9.1.1. XX Driving/Opportunity Factor
11.9.1.2. XX Driving/Opportunity Factor
11.10. France Traveler’s Diarrhea Treatment Market
11.10.1.1. XX Driving/Opportunity Factor
11.10.1.2. XX Driving/Opportunity Factor
11.11. Rest of Europe Traveler’s Diarrhea Treatment Market
11.11.1.1. XX Driving/Opportunity Factor
11.11.1.2. XX Driving/Opportunity Factor
12. Asia Pacific Traveler’s Diarrhea Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Asia-Pacific Traveler’s Diarrhea Treatment Market Size and Forecast By Drug Class
12.2.1.1. XX Driving/Opportunity Factor
12.2.1.2. XX Driving/Opportunity Factor
12.3. Asia-Pacific Traveler’s Diarrhea Treatment Market Size and Forecast By Pathogen
12.3.1.1. XX Driving/Opportunity Factor
12.3.1.2. XX Driving/Opportunity Factor
12.4. Asia-Pacific Traveler’s Diarrhea Treatment Market Size and Forecast By Patient Demographics
12.4.1.1. XX Driving/Opportunity Factor
12.4.1.2. XX Driving/Opportunity Factor
12.5. Asia-Pacific Traveler’s Diarrhea Treatment Market Size and Forecast By Route of Administration
12.5.1.1. XX Driving/Opportunity Factor
12.5.1.2. XX Driving/Opportunity Factor
12.6. Asia-Pacific Traveler’s Diarrhea Treatment Market Size and Forecast By End-User
12.6.1.1. XX Driving/Opportunity Factor
12.6.1.2. XX Driving/Opportunity Factor
12.7. Asia-Pacific Traveler’s Diarrhea Treatment Market Size and Forecast By Distribution Channel
12.7.1.1. XX Driving/Opportunity Factor
12.7.1.2. XX Driving/Opportunity Factor
12.8. China Traveler’s Diarrhea Treatment Market
12.8.1.1. XX Driving/Opportunity Factor
12.8.1.2. XX Driving/Opportunity Factor
12.9. India Traveler’s Diarrhea Treatment Market
12.9.1.1. XX Driving/Opportunity Factor
12.9.1.2. XX Driving/Opportunity Factor
12.10. Japan Traveler’s Diarrhea Treatment Market
12.10.1.1. XX Driving/Opportunity Factor
12.10.1.2. XX Driving/Opportunity Factor
12.11. Rest of Asia Pacific Traveler’s Diarrhea Treatment Market
12.11.1.1. XX Driving/Opportunity Factor
12.11.1.2. XX Driving/Opportunity Factor
13. Latin America Traveler’s Diarrhea Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
13.1. Market Overview
13.2. Latin America Traveler’s Diarrhea Treatment Market Size and Forecast By Drug Class
13.2.1.1. XX Driving/Opportunity Factor
13.2.1.2. XX Driving/Opportunity Factor
13.3. Latin America Traveler’s Diarrhea Treatment Market Size and Forecast By Pathogen
13.3.1.1. XX Driving/Opportunity Factor
13.3.1.2. XX Driving/Opportunity Factor
13.4. Latin America Traveler’s Diarrhea Treatment Market Size and Forecast By Patient Demographics
13.4.1.1. XX Driving/Opportunity Factor
13.4.1.2. XX Driving/Opportunity Factor
13.5. Latin America Traveler’s Diarrhea Treatment Market Size and Forecast By Route of Administration
13.5.1.1. XX Driving/Opportunity Factor
13.5.1.2. XX Driving/Opportunity Factor
13.6. Latin America Traveler’s Diarrhea Treatment Market Size and Forecast By End-User
13.6.1.1. XX Driving/Opportunity Factor
13.6.1.2. XX Driving/Opportunity Factor
13.7. Latin America Traveler’s Diarrhea Treatment Market Size and Forecast By Distribution Channel
13.8. Brazil Traveler’s Diarrhea Treatment Market
13.8.1.1. XX Driving/Opportunity Factor
13.8.1.2. XX Driving/Opportunity Factor
13.9. Mexico Traveler’s Diarrhea Treatment Market
13.9.1.1. XX Driving/Opportunity Factor
13.9.1.2. XX Driving/Opportunity Factor
13.10. Rest of Latin America Traveler’s Diarrhea Treatment Market
13.10.1.1. XX Driving/Opportunity Factor
13.10.1.2. XX Driving/Opportunity Factor
14. MEA Traveler’s Diarrhea Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
14.1. Market Overview
14.2. MEA Traveler’s Diarrhea Treatment Market Size and Forecast By Drug Class
14.2.1.1. XX Driving/Opportunity Factor
14.2.1.2. XX Driving/Opportunity Factor
14.3. MEA Traveler’s Diarrhea Treatment Market Size and Forecast By Pathogen
14.3.1.1. XX Driving/Opportunity Factor
14.3.1.2. XX Driving/Opportunity Factor
14.4. MEA Traveler’s Diarrhea Treatment Market Size and Forecast By Patient Demographics
14.4.1.1. XX Driving/Opportunity Factor
14.4.1.2. XX Driving/Opportunity Factor
14.5. MEA Traveler’s Diarrhea Treatment Market Size and Forecast By Route of Administration
14.5.1.1. XX Driving/Opportunity Factor
14.5.1.2. XX Driving/Opportunity Factor
14.6. MEA Traveler’s Diarrhea Treatment Market Size and Forecast By End-User
14.6.1.1. XX Driving/Opportunity Factor
14.6.1.2. XX Driving/Opportunity Factor
14.7. MEA Traveler’s Diarrhea Treatment Market Size and Forecast By Distribution Channel
14.7.1.1. XX Driving/Opportunity Factor
14.7.1.2. XX Driving/Opportunity Factor
14.8. GCC Traveler’s Diarrhea Treatment Market
14.8.1.1. XX Driving/Opportunity Factor
14.8.1.2. XX Driving/Opportunity Factor
14.9. South Africa Traveler’s Diarrhea Treatment Market
14.9.1.1. XX Driving/Opportunity Factor
14.9.1.2. XX Driving/Opportunity Factor
14.10. Rest of MEA Traveler’s Diarrhea Treatment Market
14.10.1.1. XX Driving/Opportunity Factor
14.10.1.2. XX Driving/Opportunity Factor
15. Companies in the Traveler’s Diarrhea Treatment Market
15.1. Bayer AG
15.1.1. Company Snapshot
15.1.2. Company Overview
15.1.3. Financial Performance (2015-2019)
15.1.3.1. Net Revenue
15.1.3.2. Gross Profit
15.1.3.3. Geographical Revenue, 2019
15.1.4. Product Offerings
15.1.5. Recent Initiatives (2017-2019)
15.2. Merck & Co., Inc
15.2.1. Company Snapshot
15.2.2. Company Overview
15.2.3. Financial Performance (2015-2019)
15.2.3.1. Net Revenue
15.2.3.2. Gross Profit
15.2.3.3. Geographical Revenue, 2019
15.2.4. Product Offerings
15.2.5. Recent Initiatives (2017-2019)
15.3. Johnson & Johnson Services, Inc
15.3.1. Company Snapshot
15.3.2. Company Overview
15.3.3. Financial Performance (2015-2019)
15.3.3.1. Net Revenue
15.3.3.2. Gross Profit
15.3.3.3. Geographical Revenue, 2019
15.3.4. Product Offerings
15.3.5. Recent Initiatives (2017-2019)
15.4. NOVARTIS AG
15.4.1. Company Snapshot
15.4.2. Company Overview
15.4.3. Financial Performance (2015-2019)
15.4.3.1. Net Revenue
15.4.3.2. Gross Profit
15.4.3.3. Geographical Revenue, 2019
15.4.4. Product Offerings
15.4.5. Recent Initiatives (2017-2019)
15.5. VALNEVA SE
15.5.1. Company Snapshot
15.5.2. Company Overview
15.5.3. Financial Performance (2015-2019)
15.5.3.1. Net Revenue
15.5.3.2. Gross Profit
15.5.3.3. Geographical Revenue, 2019
15.5.4. Product Offerings
15.5.5. Recent Initiatives (2017-2019)
15.6. Shanghai United Cell Biotechnology Co.,Ltd
15.6.1. Company Snapshot
15.6.2. Company Overview
15.6.3. Financial Performance (2015-2019)
15.6.3.1. Net Revenue
15.6.3.2. Gross Profit
15.6.3.3. Geographical Revenue, 2019
15.6.4. Product Offerings
15.6.5. Recent Initiatives (2017-2019)
15.7. PaxVax, Inc
15.7.1. Company Snapshot
15.7.2. Company Overview
15.7.3. Financial Performance (2015-2019)
15.7.3.1. Net Revenue
15.7.3.2. Gross Profit
15.7.3.3. Geographical Revenue, 2019
15.7.4. Product Offerings
15.7.5. Recent Initiatives (2017-2019)
15.8. Immuron
15.8.1. Company Snapshot
15.8.2. Company Overview
15.8.3. Financial Performance (2015-2019)
15.8.3.1. Net Revenue
15.8.3.2. Gross Profit
15.8.3.3. Geographical Revenue, 2019
15.8.4. Product Offerings
15.8.5. Recent Initiatives (2017-2019)
15.9. Salix Pharmaceuticals
15.9.1. Company Snapshot
15.9.2. Company Overview
15.9.3. Financial Performance (2015-2019)
15.9.3.1. Net Revenue
15.9.3.2. Gross Profit
15.9.3.3. Geographical Revenue, 2019
15.9.4. Product Offerings
15.9.5. Recent Initiatives (2017-2019)
15.10. F. Hoffmann-La Roche Ltd
15.10.1. Company Snapshot
15.10.2. Company Overview
15.10.3. Financial Performance (2015-2019)
15.10.3.1. Net Revenue
15.10.3.2. Gross Profit
15.10.3.3. Geographical Revenue, 2019
15.10.4. Product Offerings
15.10.5. Recent Initiatives (2017-2019)
15.11. Other Notable Players
16. Conclusion
17. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Traveler’s Diarrhea Treatment Market Drivers & Restraints 2021
Table 7. Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Antidiarrheal Agents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Antidiarrheal Agents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Antidiarrheal Agents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Antidiarrheal Agents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Antidiarrheal Agents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Vaccines/prophylactics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Vaccines/prophylactics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Vaccines/prophylactics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Vaccines/prophylactics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Vaccines/prophylactics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Bacteria Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Bacteria Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Bacteria Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Bacteria Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Bacteria Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Viruses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Viruses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Viruses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Viruses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Viruses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Giardiasis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Giardiasis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Giardiasis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Giardiasis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Giardiasis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Protozoa Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Protozoa Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Protozoa Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Protozoa Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Protozoa Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78. Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 79. Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 80. Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 81. Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 82. Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 83. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 84. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 85. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 86. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 87. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 88. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 89. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 90. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 91. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 92. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 93. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 94. Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 95. Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 96. Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 97. Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 98. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 99. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 100. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 101. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 102. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 103. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 104. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 105. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 106. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 107. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 108. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 109. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 110. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 111. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 112. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 113. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 114. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 115. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 116. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 117. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 118. Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 119. Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 120. Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 121. Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 122. Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 123. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 124. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 125. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 126. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 127. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 128. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 129. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 130. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 131. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 132. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 133. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 134. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 135. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 136. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 137. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 138. North America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 139. North America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 140. North America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 141. North America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 142. North America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 143. North America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 144. North America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 145. North America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 146. North America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 147. North America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 148. North America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 149. North America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 150. North America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 151. North America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 152. North America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 153. North America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 154. North America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 155. North America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 156. North America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 157. North America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 158. North America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 159. North America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 160. North America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 161. North America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 162. North America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 163. North America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 164. North America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 165. North America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 166. North America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 167. North America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 168. North America Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 169. North America Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 170. North America Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 171. North America Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 172. North America Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 173. US Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 174. US Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 175. US Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 176. US Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 177. US Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 178. Canada Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 179. Canada Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 180. Canada Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 181. Canada Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 182. Canada Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 183. Europe Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Table 184. Europe Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 185. Europe Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 186. Europe Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 187. Europe Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 188. Europe Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 189. Europe Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 190. Europe Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 191. Europe Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 192. Europe Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 193. Europe Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 194. Europe Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 195. Europe Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 196. Europe Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 197. Europe Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 198. Europe Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. Europe Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. Europe Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. Europe Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Europe Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203. Europe Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. Europe Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205. Europe Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. Europe Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. Europe Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208. Europe Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209. Europe Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. Europe Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. Europe Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212. Europe Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 213. Europe Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 214. Europe Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 215. Europe Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 216. UK Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 217. UK Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 218. UK Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 219. UK Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 220. UK Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 221. Germany Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 222. Germany Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 223. Germany Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 224. Germany Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 225. Germany Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 226. France Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 227. France Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 228. France Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 229. France Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 230. France Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 231. Rest of Europe Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 232. Rest of Europe Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233. Rest of Europe Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234. Rest of Europe Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235. Rest of Europe Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 237. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 238. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 239. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 240. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 241. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 242. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 243. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 244. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 245. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 246. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 247. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 248. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 249. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 250. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 251. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 252. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 253. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 254. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 255. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 256. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 257. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 258. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 259. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 260. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 261. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 262. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 263. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 264. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 265. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 266. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 267. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 268. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 269. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 270. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 271. China Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 272. China Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 273. China Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 274. China Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 275. China Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 276. India Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 277. India Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 278. India Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 279. India Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 280. India Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 281. Japan Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 282. Japan Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 283. Japan Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 284. Japan Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 285. Japan Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 286. RoAPAC Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 287. RoAPAC Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 288. RoAPAC Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 289. RoAPAC Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 290. RoAPAC Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 291. Middle East Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 292. Middle East Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 293. Middle East Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 294. Middle East Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 295. Middle East Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 296. Middle East Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 297. Middle East Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 298. Middle East Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 299. Middle East Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 300. Middle East Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 301. Middle East Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 302. Middle East Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 303. Middle East Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 304. Middle East Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 305. Middle East Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 306. Middle East Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 307. Middle East Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 308. Middle East Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 309. Middle East Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 310. Middle East Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 311. Middle East Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 312. Middle East Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 313. Middle East Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 314. Middle East Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 315. Middle East Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 316. Middle East Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 317. Middle East Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 318. Middle East Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 319. Middle East Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 320. Middle East Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 321. Latin America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 322. Latin America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 323. Latin America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 324. Latin America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 325. Latin America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 326. Latin America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 327. Latin America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 328. Latin America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 329. Latin America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 330. Latin America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 331. Latin America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 332. Latin America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 333. Latin America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 334. Latin America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 335. Latin America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 336. Latin America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 337. Latin America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 338. Latin America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 339. Latin America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 340. Latin America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 341. Latin America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 342. Latin America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 343. Latin America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 344. Latin America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 345. Latin America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 346. Latin America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 347. Latin America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 348. Latin America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 349. Latin America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 350. Latin America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 351. Africa Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 352. Africa Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 353. Africa Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 354. Africa Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 355. Africa Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 356. Africa Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 357. Africa Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 358. Africa Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 359. Africa Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 360. Africa Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 361. Africa Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 362. Africa Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 363. Africa Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 364. Africa Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 365. Africa Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 366. Africa Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 367. Africa Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 368. Africa Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 369. Africa Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 370. Africa Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 371. Africa Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 372. Africa Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 373. Africa Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 374. Africa Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 375. Africa Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 376. Africa Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 377. Africa Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 378. Africa Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 379. Africa Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 380. Africa Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 381. Leading 10 Traveler’s Diarrhea Treatment Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 382. Bayer AG Profile 2019 (CEO, HQ, Founded, Website)
Table 383. Bayer AG Traveler’s Diarrhea Treatment Product Offering (Segment, Product Offerings)
Table 384. Merck & Co., IncProfile 2019 (CEO, HQ, Founded, Website)
Table 385. Merck & Co., IncTraveler’s Diarrhea Treatment Product Offering (Segment, Product Offerings)
Table 386. Johnson & Johnson Services, Inc Profile 2019 (CEO, HQ, Founded, Website)
Table 387. Johnson & Johnson Services, Inc.Traveler’s Diarrhea Treatment Product Offering (Segment, Product Offerings)
Table 388. NOVARTIS AG Profile 2019 (CEO, HQ, Founded, Website)
Table 389. NOVARTIS AG Traveler’s Diarrhea Treatment Product Offering (Segment, Product Offerings)
Table 390. VALNEVA SE Profile 2019 (CEO, HQ, Founded, Website)
Table 391. VALNEVA SE Traveler’s Diarrhea Treatment Product Offering (Segment, Product Offerings)
Table 392. Shanghai United Cell Biotechnology Co.,Ltd Profile 2019 (CEO, HQ, Founded, Website)
Table 393. Shanghai United Cell Biotechnology Co.,Ltd Traveler’s Diarrhea Treatment Product Offering (Segment, Product Offerings)
Table 394. PaxVax, Inc Profile 2019 (CEO, HQ, Founded, Website)
Table 395. PaxVax, Inc Traveler’s Diarrhea Treatment Product Offering (Segment, Product Offerings)
Table 396. Immuron Profile 2019 (CEO, HQ, Founded, Website)
Table 397. Immuron Traveler’s Diarrhea Treatment Product Offering (Segment, Product Offerings)
Table 398. Salix Pharmaceuticals Profile 2019 (CEO, HQ, Founded, Website)
Table 399. Salix Pharmaceuticals Traveler’s Diarrhea Treatment Product Offering (Segment, Product Offerings)
Table 400. F. Hoffmann-La Roche Ltd Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 401. F. Hoffmann-La Roche Ltd Traveler’s Diarrhea Treatment Product Offering (Segment, Product Offerings)
Table 402. Other Companies Involved in the Traveler’s Diarrhea Treatment Market 2021 (Company, Location)
LIST OF FIGURES
Figure 1. Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 2. Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 3. Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 4. Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 5. Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 6. Traveler’s Diarrhea Treatment Market Drivers & Restraints 2021
Figure 7. Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 8. Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 9. Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 10. Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 11. Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 12. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 13. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 14. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 15. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 16. Oral Rehydration Therapy (ORS) Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 17. Antidiarrheal Agents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 18. Antidiarrheal Agents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 19. Antidiarrheal Agents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 20. Antidiarrheal Agents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 21. Antidiarrheal Agents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 22. Vaccines/prophylactics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 23. Vaccines/prophylactics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 24. Vaccines/prophylactics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 25. Vaccines/prophylactics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 26. Vaccines/prophylactics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 27. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 28. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 29. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 30. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 31. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 32. Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 33. Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 34. Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 35. Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 36. Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 37. Bacteria Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 38. Bacteria Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 39. Bacteria Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 40. Bacteria Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 41. Bacteria Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 42. Viruses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 43. Viruses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 44. Viruses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 45. Viruses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 46. Viruses Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 47. Giardiasis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 48. Giardiasis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 49. Giardiasis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 50. Giardiasis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 51. Giardiasis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 52. Protozoa Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 53. Protozoa Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 54. Protozoa Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 55. Protozoa Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 56. Protozoa Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 57. Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 58. Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 59. Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 60. Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 61. Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 62. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 63. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 64. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 65. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 66. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 67. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 68. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 69. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 70. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 71. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 72. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 73. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 74. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 75. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 76. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 77. Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 78. Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 79. Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 80. Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 81. Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 82. Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 83. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 84. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 85. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 86. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 87. Oral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 88. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 89. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 90. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 91. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 92. Parenteral Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 93. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 94. Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 95. Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 96. Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 97. Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 98. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 99. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 100. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 101. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 102. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 103. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 104. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 105. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 106. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 107. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 108. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 109. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 110. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 111. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 112. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 113. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 114. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 115. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 116. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 117. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 118. Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 119. Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 120. Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 121. Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 122. Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 123. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 124. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 125. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 126. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 127. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 128. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 129. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 130. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 131. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 132. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 133. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 134. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 135. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 136. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 137. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 138. North America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 139. North America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 140. North America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 141. North America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 142. North America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 143. North America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 144. North America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 145. North America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 146. North America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 147. North America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 148. North America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 149. North America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 150. North America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 151. North America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 152. North America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 153. North America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 154. North America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 155. North America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 156. North America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 157. North America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 158. North America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 159. North America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 160. North America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 161. North America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 162. North America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 163. North America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 164. North America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 165. North America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 166. North America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 167. North America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 168. North America Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 169. North America Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 170. North America Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 171. North America Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 172. North America Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 173. US Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 174. US Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 175. US Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 176. US Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 177. US Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 178. Canada Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 179. Canada Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 180. Canada Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 181. Canada Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 182. Canada Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 183. Europe Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Figure 184. Europe Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 185. Europe Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 186. Europe Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 187. Europe Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 188. Europe Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 189. Europe Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 190. Europe Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 191. Europe Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 192. Europe Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 193. Europe Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 194. Europe Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 195. Europe Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 196. Europe Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 197. Europe Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 198. Europe Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 199. Europe Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 200. Europe Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 201. Europe Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 202. Europe Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 203. Europe Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 204. Europe Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 205. Europe Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 206. Europe Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 207. Europe Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 208. Europe Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 209. Europe Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 210. Europe Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 211. Europe Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 212. Europe Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 213. Europe Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 214. Europe Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 215. Europe Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 216. UK Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 217. UK Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 218. UK Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 219. UK Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 220. UK Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 221. Germany Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 222. Germany Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 223. Germany Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 224. Germany Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 225. Germany Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 226. France Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 227. France Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 228. France Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 229. France Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 230. France Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 231. Rest of Europe Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 232. Rest of Europe Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 233. Rest of Europe Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 234. Rest of Europe Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 235. Rest of Europe Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 236. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 237. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 238. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 239. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 240. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 241. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 242. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 243. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 244. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 245. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 246. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 247. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 248. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 249. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 250. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 251. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 252. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 253. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 254. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 255. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 256. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 257. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 258. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 259. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 260. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 261. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 262. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 263. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 264. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 265. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 266. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 267. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 268. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 269. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 270. Asia Pacific Traveler’s Diarrhea Treatment Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 271. China Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 272. China Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 273. China Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 274. China Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 275. China Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 276. India Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 277. India Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 278. India Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 279. India Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 280. India Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 281. Japan Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 282. Japan Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 283. Japan Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 284. Japan Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 285. Japan Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 286. RoAPAC Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 287. RoAPAC Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 288. RoAPAC Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 289. RoAPAC Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 290. RoAPAC Traveler’s Diarrhea Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 291. Middle East Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 292. Middle East Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 293. Middle East Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 294. Middle East Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 295. Middle East Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 296. Middle East Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 297. Middle East Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 298. Middle East Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 299. Middle East Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 300. Middle East Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 301. Middle East Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 302. Middle East Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 303. Middle East Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 304. Middle East Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 305. Middle East Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 306. Middle East Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 307. Middle East Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 308. Middle East Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 309. Middle East Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 310. Middle East Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 311. Middle East Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 312. Middle East Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 313. Middle East Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 314. Middle East Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 315. Middle East Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 316. Middle East Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 317. Middle East Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 318. Middle East Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 319. Middle East Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 320. Middle East Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 321. Latin America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 322. Latin America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 323. Latin America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 324. Latin America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 325. Latin America Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 326. Latin America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 327. Latin America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 328. Latin America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 329. Latin America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 330. Latin America Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 331. Latin America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 332. Latin America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 333. Latin America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 334. Latin America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 335. Latin America Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 336. Latin America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 337. Latin America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 338. Latin America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 339. Latin America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 340. Latin America Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 341. Latin America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 342. Latin America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 343. Latin America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 344. Latin America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 345. Latin America Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 346. Latin America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 347. Latin America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 348. Latin America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 349. Latin America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 350. Latin America Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 351. Africa Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 352. Africa Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 353. Africa Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 354. Africa Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 355. Africa Traveler’s Diarrhea Treatment Market Forecast By Drug Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 356. Africa Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 357. Africa Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 358. Africa Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 359. Africa Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 360. Africa Traveler’s Diarrhea Treatment Market Forecast By Pathogen 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 361. Africa Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 362. Africa Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 363. Africa Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 364. Africa Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 365. Africa Traveler’s Diarrhea Treatment Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 366. Africa Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 367. Africa Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 368. Africa Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 369. Africa Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 370. Africa Traveler’s Diarrhea Treatment Market Forecast By Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 371. Africa Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 372. Africa Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 373. Africa Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 374. Africa Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 375. Africa Traveler’s Diarrhea Treatment Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 376. Africa Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 377. Africa Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 378. Africa Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 379. Africa Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 380. Africa Traveler’s Diarrhea Treatment Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 381. Porter’s Five Force Analysis
Companies Mentioned
1. Basilea Pharmaceutica Ltd
2. Eli Lilly and Company
3. Delcath Systems Inc
4. BridgeBio Inc
5. Agios, Inc
6. GlaxoSmithKline PLC
7. Biomarin Pharmaceutical Inc
8. Grifols SA
9. UCB SA
10. Eisai Co Ltd
11. Novo Nordisk A/S
12. Alexion Pharmaceuticals Inc
13. Takeda Pharmaceutical Co Ltd
14. Chugai Pharmaceutical Co Ltd
15. Perrigo Company PLC
16. Astellas Pharma Inc
17. Mitsubishi Tanabe Pharma Corp
18. Johnson & Johnson
19. Shanghai Fosun Pharmaceutical Group Co Ltd
20. Jiangsu Hengrui Medicine Co Ltd
21. Allergan plc
22. Shire PLC
23. Kyowa Hakko Kirin Co Ltd
24. Pfizer Inc
25. Taisho Pharmaceutical Holdings Co Ltd
26. MYL.O
27. Zoetis Inc
28. Bristol-Myers Squibb Co
29. Merck & Co Inc
30. AbbVie Inc
31. Jazz Pharmaceuticals PLC
32. Sumitomo Dainippon Pharma Co Ltd
33. AstraZeneca PLC
34. China Grand Automotive Services Co Ltd
35. Daiichi Sankyo Co Ltd
36. Novartis AG
37. Tasly Pharmaceutical Group Co Ltd
38. CSL Ltd
39. Biogen Inc
40. Orion Oyj
41. Bayer AG
42. CSPC Pharmaceutical Group Ltd
43. Sanofi SA
44. Roche Holding AG
45. Ono Pharmaceutical Co Ltd
46. Beijing Tongrentang Co Ltd
47. Kangmei Pharmaceutical Co Ltd
48. Ipsen SA
49. Abbott Laboratories
50. Shionogi & Co Ltd
51. Eli Lilly and Co
52. Recordati Industria Chimica e Farmaceutica SpA
53. Hikma Pharmaceuticals PLC
54. Teva Pharmaceutical Industries Ltd
55. Merck KGaA
Companies Profiled in the Report
1. Bayer AG
2. Merck & Co., Inc
3. Johnson & Johnson Services, Inc
4. Novartis AG
5. Valneva SE
6. Shanghai United Cell Biotechnology Co.,Ltd
7. PaxVax, Inc
8. Immuron
9. Salix Pharmaceuticals
10. F. Hoffmann-La Roche Ltd
List of Companies Mentioned in the Report:
1. Basilea Pharmaceutica Ltd
2. Eli Lilly and Company
3. Delcath Systems Inc
4. BridgeBio Inc
5. Agios, Inc
6. GlaxoSmithKline PLC
7. Biomarin Pharmaceutical Inc
8. Grifols SA
9. UCB SA
10. Eisai Co Ltd
11. Novo Nordisk A/S
12. Alexion Pharmaceuticals Inc
13. Takeda Pharmaceutical Co Ltd
14. Chugai Pharmaceutical Co Ltd
15. Perrigo Company PLC
16. Astellas Pharma Inc
17. Mitsubishi Tanabe Pharma Corp
18. Johnson & Johnson
19. Shanghai Fosun Pharmaceutical Group Co Ltd
20. Jiangsu Hengrui Medicine Co Ltd
21. Allergan plc
22. Shire PLC
23. Kyowa Hakko Kirin Co Ltd
24. Pfizer Inc
25. Taisho Pharmaceutical Holdings Co Ltd
26. MYL.O
27. Zoetis Inc
28. Bristol-Myers Squibb Co
29. Merck & Co Inc
30. AbbVie Inc
31. Jazz Pharmaceuticals PLC
32. Sumitomo Dainippon Pharma Co Ltd
33. AstraZeneca PLC
34. China Grand Automotive Services Co Ltd
35. Daiichi Sankyo Co Ltd
36. Novartis AG
37. Tasly Pharmaceutical Group Co Ltd
38. CSL Ltd
39. Biogen Inc
40. Orion Oyj
41. Bayer AG
42. CSPC Pharmaceutical Group Ltd
43. Sanofi SA
44. Roche Holding AG
45. Ono Pharmaceutical Co Ltd
46. Beijing Tongrentang Co Ltd
47. Kangmei Pharmaceutical Co Ltd
48. Ipsen SA
49. Abbott Laboratories
50. Shionogi & Co Ltd
51. Eli Lilly and Co
52. Recordati Industria Chimica e Farmaceutica SpA
53. Hikma Pharmaceuticals PLC
54. Teva Pharmaceutical Industries Ltd
55. Merck KGaA
List of Organizations Mentioned in the Report:
1. Centre for Pharmaceutical Administration Health Sciences Authority
2. Central Drug Standard Control Organization (CDSCO)
3. Organisation for Economic Co-operation and Development (OECD)
4. European Medicines Agency (EMA)
5. Food and Drug Administration (FDA)
6. National Institutes of Health (NIH)
7. United Nations (UN)
8. United Nations Office on Drugs and Crime (UNODC)
9. United Nations Statistics Division (UNSD)
10. Statistical Office of the European Union (EUROSTAT)
11. World Health Organization (WHO)
12. The National Medical Products Administration (NMPA)
13. Indian Council of Medical Research (ICMR)
14. The Therapeutic Goods Administration
15. The Federal Institute for Drugs and Medical Devices (BfArM)
1. Bayer AG
2. Merck & Co., Inc
3. Johnson & Johnson Services, Inc
4. Novartis AG
5. Valneva SE
6. Shanghai United Cell Biotechnology Co.,Ltd
7. PaxVax, Inc
8. Immuron
9. Salix Pharmaceuticals
10. F. Hoffmann-La Roche Ltd
List of Companies Mentioned in the Report:
1. Basilea Pharmaceutica Ltd
2. Eli Lilly and Company
3. Delcath Systems Inc
4. BridgeBio Inc
5. Agios, Inc
6. GlaxoSmithKline PLC
7. Biomarin Pharmaceutical Inc
8. Grifols SA
9. UCB SA
10. Eisai Co Ltd
11. Novo Nordisk A/S
12. Alexion Pharmaceuticals Inc
13. Takeda Pharmaceutical Co Ltd
14. Chugai Pharmaceutical Co Ltd
15. Perrigo Company PLC
16. Astellas Pharma Inc
17. Mitsubishi Tanabe Pharma Corp
18. Johnson & Johnson
19. Shanghai Fosun Pharmaceutical Group Co Ltd
20. Jiangsu Hengrui Medicine Co Ltd
21. Allergan plc
22. Shire PLC
23. Kyowa Hakko Kirin Co Ltd
24. Pfizer Inc
25. Taisho Pharmaceutical Holdings Co Ltd
26. MYL.O
27. Zoetis Inc
28. Bristol-Myers Squibb Co
29. Merck & Co Inc
30. AbbVie Inc
31. Jazz Pharmaceuticals PLC
32. Sumitomo Dainippon Pharma Co Ltd
33. AstraZeneca PLC
34. China Grand Automotive Services Co Ltd
35. Daiichi Sankyo Co Ltd
36. Novartis AG
37. Tasly Pharmaceutical Group Co Ltd
38. CSL Ltd
39. Biogen Inc
40. Orion Oyj
41. Bayer AG
42. CSPC Pharmaceutical Group Ltd
43. Sanofi SA
44. Roche Holding AG
45. Ono Pharmaceutical Co Ltd
46. Beijing Tongrentang Co Ltd
47. Kangmei Pharmaceutical Co Ltd
48. Ipsen SA
49. Abbott Laboratories
50. Shionogi & Co Ltd
51. Eli Lilly and Co
52. Recordati Industria Chimica e Farmaceutica SpA
53. Hikma Pharmaceuticals PLC
54. Teva Pharmaceutical Industries Ltd
55. Merck KGaA
List of Organizations Mentioned in the Report:
1. Centre for Pharmaceutical Administration Health Sciences Authority
2. Central Drug Standard Control Organization (CDSCO)
3. Organisation for Economic Co-operation and Development (OECD)
4. European Medicines Agency (EMA)
5. Food and Drug Administration (FDA)
6. National Institutes of Health (NIH)
7. United Nations (UN)
8. United Nations Office on Drugs and Crime (UNODC)
9. United Nations Statistics Division (UNSD)
10. Statistical Office of the European Union (EUROSTAT)
11. World Health Organization (WHO)
12. The National Medical Products Administration (NMPA)
13. Indian Council of Medical Research (ICMR)
14. The Therapeutic Goods Administration
15. The Federal Institute for Drugs and Medical Devices (BfArM)
Download sample pages
Complete the form below to download your free sample pages for Traveller’s Diarrhoea Treatment Market Report 2021-2031Download sample pages
Complete the form below to download your free sample pages for Traveller’s Diarrhoea Treatment Market Report 2021-2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033
The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.
21 September 2023
Visiongain Publishes Contract Research Organisations (CROs) Market Report 2023-2033
The global Contract Research Organisations (CROs) market was valued at US$68.9 billion in 2023 and is projected to grow at a CAGR of 10.6% during the forecast period 2023-2033.
14 September 2023
Visiongain Publishes Stem Cell Therapy Contract Manufacturing Market Report 2023-2033
The global Stem Cell Therapy Contract Manufacturing market was valued at US$2,495.1 million in 2022 and is projected to grow at a CAGR of 12.4% during the forecast period 2023-2033.
13 September 2023
Visiongain Publishes Immuno-Oncology Clinical Trials Market Report 2023-2033
Immuno-Oncology Clinical Trials market is valued at US$6,849.8 million in 2023 and is projected to grow at a CAGR of 11.3% during the forecast period 2023-2033.
11 September 2023
